Investor Presentation • Aug 7, 2024
Investor Presentation
Open in ViewerOpens in native device viewer
01 Overview
02 Key Figures HY/2024
03 Outlook 2024
04 Appendix
Group revenue despite declining economic momentum stable at EUR 51.6 million (HY/2023: EUR 52.7 million)
Record result due to profitability boost: operating EBIT margin rises from $12.9 \%$ to $14.6 \%$
Future programme HERO@ZERO as growth strategy shows first successes
Stable order situation in medical technology, aviation, life science and specialist industries
Order backlog as of 30 June 2024 remains at a high level of EUR 20.0 million (31/12/2023: EUR 20.5 million)
Increase in Group equity to EUR 62.4 million (31/12/2023: EUR 57.6 million); solid equity ratio of $64.5 \%$ (31/12/2023: 61.5\%)
Guidance for 2024 confirmed: Revenue between EUR 100 million and EUR 107 million, EBIT between EUR 12 million and EUR 15 million expected
Dividend increase of $25 \%$ to EUR 0.25 per share (2023: EUR 0.20)

| in EUR million | HY/2024 | HY/2023 | Change |
|---|---|---|---|
| Revenue | 51.6 | 52.7 | $-2.1 \%$ |
| EBITDA | 10.1 | 9.4 | $+7.4 \%$ |
| EBIT (operating) |
7.5 | 6.8 | $+10.8 \%$ |
| Consolidated result |
4.8 | 4.3 | $+13.4 \%$ |
| EPS (in EUR) |
0.50 | 0.44 | $+13.6 \%$ |
Group equity in EUR million and equity ratio

Dividend/EPS

Development of the share price from April 2023 to July 2024 in EUR (on Xetra basis)

Analyst ratings
Consensus expectations revenue in EUR million

2024e 2025e 2026e
Source: Bloomberg


SMC Research 13.05.2024 BUY - EUR 15.00

Revenue
in EUR million

EBIT (operating)
in EUR million

EBITDA
in EUR million

EPS
in EUR

EBIT
in EUR million

EBITDA
in EUR million

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR

EBIT
in EUR
),
-
| 7 August | Half-Year Report 2024 |
|---|---|
| 21 - 22 August | HIT - Hamburger Investors Days |
| 6 November | Quarterly Statement 3/2024 |
| 13 November | MKK - Munich Captial Markets Conference |
Connecting Values
Willy-Brandt-Allee 300
45891 Gelsenkirchen
Germany
www.masterflexgroup.com
Tel +49 209970770
Fax +49 2099707733
[email protected]
CROSS ALLIANCE communication GmbH
Susan Hoffmeister
Bahnhofstraße 98
82166 Gräfelfing/München
www.crossalliance.de
Tel +89 125090333
[email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.